Manufacturer record
ANG Lifesciences India Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
32 batches manufactured by ANG Lifesciences India Ltd (Himachal Pradesh) were declared Not of Standard Quality between July 2019 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
32 records linked to ANG Lifesciences India Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
32Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
32
NSQ batches since 2019
18
Products affected
Description
Most common failure
May 2025
Latest alert
Flagged batches per year
2019 · 12020 · 22021 · 12022 · 102023 · 82024 · 62025 · 4
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole for Injection BP 40 mg | AA013026Mfg 2023-06 · Exp 2025-05 | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Pantoprazole for Injection BP 40 mg | AA013043Mfg 2023-08 · Exp 2025-07 | Clarity and colour of solutionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Pantoprazole for Injection BP 40 mg | AA013047Mfg 2023-09 · Exp 2025-08 | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Amoxycillin & Potassium Clavulanate Injection IP. | AB193049AMfg 2023-05 · Exp 2025-04 | Assay (Content of Clavulanic Acid)Assay | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| Piperacillin and Tazobactam Injection IP (CASIDTAZ P Injection) | AB154006BMfg 2024-06 · Exp 2026-05 | Particulate MatterParticulate matter | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Cefoperazone and Sulbactam for Injection (KEFZONE-S INJECTION) | AB234007CMfg 2024-06 · Exp 2026-05 | Particulate MatterParticulate matter | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Enalapril Maelate Tablets IP 5 mg | T013002Mfg 2023-06 · Exp 2025-05 | Assay of Enalapril MaleateAssay | RDTL ChandigarhCDSCO lab | Mar 2024 |
| DICLOFENAC SODIUM INJECTION I.P. 75mg/3ml | I213109Mfg 2023-07 · Exp 2025-06 | DescriptionDescription | RDTL GuwahatiState lab | Feb 2024 |
| Folic Acid Tablets IP 5 mg | T112005Mfg 2022-05 · Exp 2024-04 | Description as the tablets are brittle & shows mottled appearanceDescription | CDTL MumbaiCDSCO lab | Jan 2024 |
| Diclofenac Sodium Injection IP | I213108Mfg 2023-07 · Exp 2025-06 | Particulate matter and DescriptionDescription | RDTL GuwahatiState lab | Jan 2024 |
| Ciprofloxacin Tablets I.P. 500 mg | T032022Mfg 2022-11 · Exp 2024-10 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2023 |
| CIPROFLOXACIN TABLETS I.P. 500 mg. | T032023Mfg 2022-11 · Exp 2024-10 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2023 |
| Ascorbic Acid Tablets I.P. 500 mg. | T392017Mfg 2022-03 · Exp 2024-02 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2023 |
| Telmisartan Tablets I.P. 40mg. | T101004Mfg 2021-09 · Exp 2023-08 | DescriptionDescription | RDTL GuwahatiState lab | Jul 2023 |
| Folic Acid Tablets IP 5mg | T112005Mfg 2022-05 · Exp 2024-04 | Description & Hydrolysis ProductsDescription | CDL KolkataCDSCO lab | Jul 2023 |
| Glimepiride Tablets IP 2 mg | T192009Mfg 2022-05 · Exp 2024-04 | Dissolution of GlimepirideDissolution | RDTL ChandigarhCDSCO lab | May 2023 |
| Telmisartan Tablets IP 40 mg | T101004Mfg 2021-09 · Exp 2023-08 | Dissolution & DescriptionDissolution | RDTL GuwahatiState lab | Mar 2023 |
| Ascorbic Acid Tablets IP 500mg | T392012Mfg 2022-01 · Exp 2023-12 | DescriptionDescription | RDTL GuwahatiState lab | Mar 2023 |
| Telmisartan Tablets IP 40 mg | T101006Mfg 2021-09 · Exp 2023-08 | DescriptionDescription | RDTL GuwahatiState lab | Nov 2022 |
| Paracetamol Tablets IP 650mg | T120214Mfg 2022-04 · Exp 2024-03 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2022 |
| ONDASETRON TABLETS IP 4 mg | T351001Mfg 2021-08 · Exp 2023-07 | Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Oct 2022 |
| Paracetamol Tablets IP 650 mg | T120210Mfg 2022-02 · Exp 2024-01 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Ascorbic Acid Tablets IP 500 mg | T392006Mfg 2022-01 · Exp 2023-12 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| Paracetamol Tablets I.P. 650 mg | BTPM110Mfg 2021-09 · Exp 2023-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2022 |
| Paracetamol Tablets IP 650 mg | BTPT-107Mfg 2021-07 · Exp 2023-06 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| ENALAPRIL MALEATE TABLETS I.P. 5mg | T012001Mfg 2022-02 · Exp 2024-01 | Description ,Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Jul 2022 |
| Domperidone Tablets I.P. 10 mg | T141001Mfg 2021-07 · Exp 2023-06 | AssayAssay | CDL KolkataCDSCO lab | Feb 2022 |
| Pantoprazole for Injection B.P. 40 mg | AA011068Mfg 2021-04 · Exp 2023-03 | SterilitySterility | CDL KolkataCDSCO lab | Jan 2022 |
| (PANTOPRAZOLE FOR INJECTION BP 40 MG) | AA010102Mfg 2020-05 · Exp 2022-04 | Particulate matterParticulate matter | RDTL ChandigarhState lab | Dec 2021 |
| PANTOPRAZOLE SODIUM TABLETS IP 40 MG | ATPP-2011Mfg 2020-06 · Exp 2022-05 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Dec 2020 |
| Cefotaxime Injection IP | AB029001AMfg 2019-02 · Exp 2021-01 | Related SubstancesRelated substances | RDTL ChandigarhState lab | Apr 2020 |
| (Cefotaxime Injection IP) | B028004AMfg 2018-07 · Exp 2020-06 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Jul 2019 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP | 825D167 | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | May 2026 |
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Jan 2026 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.